Prescott Group Capital Management’s Idexx Laboratories IDXX Stock Holding History

Prescott Group Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-21,758	Closed	-$1.62M	–	165
2015 Q3	$1.62M	Hold	21,758	–	–	0.39%	76
2015 Q2	$1.4M	Buy	21,758 +3,758	+21%	+$260K	0.28%	102
2015 Q1	$1.39M	Hold	18,000	–	–	0.28%	101
2014 Q4	$1.33M	Buy	+18,000	New	+$1.26M	0.22%	124

Other funds holding IDXX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Prescott Group Capital Management's IDXX Position: Q4 2015 in Review

Prescott Group Capital Management sold out of Idexx Laboratories (IDXX) in Q4 2015, closing a stake of 21,758 shares — an estimated $1.62M sold.

Prescott Group Capital Management first reported a position in IDXX in Q4 2014 and held it in 4 quarters. The position peaked at $1.62M in Q3 2015. 350 funds tracked by Wall St. Rank hold IDXX as of Q4 2015.

Prescott Group Capital Management reported no remaining Idexx Laboratories position as of Q4 2015 after selling out during the quarter.
Prescott Group Capital Management sold 21,758 Idexx Laboratories shares in Q4 2015, an estimated $1.62M.
Prescott Group Capital Management first reported a position in Idexx Laboratories in Q4 2014 and held it in 4 quarters.
Prescott Group Capital Management's Idexx Laboratories position peaked at $1.62M in Q3 2015.
350 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2015.

Based on Prescott Group Capital Management's 13F filing for Q4 2015, filed 26 Jan 2016.